I am a cancer researcher with a strong background in innate immune regulation and cancer metabolism. In my previous works, I established SIRPα as a novel myeloid immune checkpoint/biomarker and provided a foundation for developing therapies that target myeloid cells to enhance immunotherapy efficacy. My research has also advanced understanding of metabolism biomarkers associated with antitumor responses. Currently, I am expanding my expertise to study diet–immune–metabolite-tumor interactions. My ongoing work investigates how high-fructose diets alter gut microbiota composition and drive immunometabolic reprogramming of immune cells. I have now identified several metabolism biomarkers related to fructose-induced colorectal cancer. Further work will focus on verification and utilization of them. I am welcome to any possible cooperation regarding cancer, metabolism, immunology and diet.
I am a cancer researcher with a strong background in innate immune regulation and cancer metabolism. In my previous works, I established SIRPα as a novel myeloid immune checkpoint/biomarker and provided a foundation for developing therapies that target myeloid cells to enhance immunotherapy efficacy. My research has also advanced understanding of metabolism biomarkers associated with antitumor responses. Currently, I am expanding my expertise to study diet–immune–metabolite-tumor interactions. My ongoing work investigates how high-fructose diets alter gut microbiota composition and drive immunometabolic reprogramming of immune cells. I have now identified several metabolism biomarkers related to fructose-induced colorectal cancer. Further work will focus on verification and utilization of them. I am welcome to any possible cooperation regarding cancer, metabolism, immunology and diet.